This is a disclosure report regarding financial/non-financial relationships with for-profit/non-profit healthcare organizations.
Pharmaceutical companies with potential conflict of interest
- In the last three years, honoria for attending advisory boards from Pierre Faber, Bayer, Novartis, BMS, Cybrexa, Ellipses, CV6 Therapeutics, Immunocore, Genmab, Astex Therapeutics, Medivir, and Sanofi Aventis.
- Honoraria for working as an IDMC member for Alligator Biosciences, GSK, Onxeo and SOTIO Biotech AGI
- Honoraria for delivery of educational talks or chairing educational meetings by AstraZeneca, Novartis, Bayer and BMS.
- Funds to support attendance at conferences from MSD and BMS.
Other affiliations with potential conflict of interest
- No partnerships to disclose.
Last updated on 12 January 2022